TransEnterix Strikes $25M Deal with Chicago Investor

RESEARCH TRIANGLE PARK, N.C. — Lincoln Park Capital, an institutional investor based in Chicago, has struck a deal to purchase as much as $25 million of shares in Triangle-based medical device firm TransEnterix.

“The Company expects this Commitment to provide us with additional balance sheet strength and to help continue funding our [surgical robot] Senhance regulatory and commercial efforts," TransEnterix CEO Todd Pope said in a statement.

Back to news